CBOA
ELV icon

Commonwealth Bank of Australia’s Elevance Health ELV Stock Holding History

Commonwealth Bank of Australia’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-44,528
Closed -$12.6M – 311
2019
Q2 		$12.6M Sell
44,528
-12,747
-22% -$3.48M 0.12% 114
2019
Q1 		$16.4M Buy
57,275
+9,520
+20% +$2.75M 0.16% 92
2018
Q4 		$12.5M Buy
47,755
+821
+2% +$226K 0.14% 102
2018
Q3 		$12.9M Sell
46,934
-4,729
-9% -$1.23M 0.12% 118
2018
Q2 		$12.3M Sell
51,663
-2,385
-4% -$552K 0.12% 116
2018
Q1 		$11.9M Sell
54,048
-9,186
-15% -$2.16M 0.13% 120
2017
Q4 		$14.2M Sell
63,234
-3,792
-6% -$808K 0.14% 124
2017
Q3 		$12.7M Buy
67,026
+5,080
+8% +$967K 0.12% 129
2017
Q2 		$11.7M Buy
61,946
+1,221
+2% +$219K 0.12% 127
2017
Q1 		$10M Buy
60,725
+615
+1% +$97.8K 0.11% 129
2016
Q4 		$8.64M Buy
60,110
+3,439
+6% +$460K 0.11% 133
2016
Q3 		$7.1M Sell
56,671
-3,500
-6% -$452K 0.08% 144
2016
Q2 		$7.9M Sell
60,171
-3,110
-5% -$426K 0.09% 138
2016
Q1 		$8.79M Buy
63,281
+196
+0.3% +$26.2K 0.11% 125
2015
Q4 		$8.8M Buy
63,085
+2,199
+4% +$303K 0.11% 120
2015
Q3 		$8.52M Buy
60,886
+111
+0.2% +$16.7K 0.11% 124
2015
Q2 		$9.98M Sell
60,775
-9,464
-13% -$1.51M 0.13% 106
2015
Q1 		$10.8M Sell
70,239
-8,000
-10% -$1.14M 0.15% 105
2014
Q4 		$9.83M Sell
78,239
-9,172
-10% -$1.13M 0.14% 100
2014
Q3 		$10.5M Sell
87,411
-2,000
-2% -$229K 0.14% 113
2014
Q2 		$9.62M Sell
89,411
-40,302
-31% -$4.15M 0.13% 115
2014
Q1 		$12.9M Sell
129,713
-144,437
-53% -$13.1M 0.08% 240
2013
Q4 		$25.3M Sell
274,150
-72,559
-21% -$6.45M 0.17% 130
2013
Q3 		$29M Buy
346,709
+24,296
+8% +$2.08M 0.21% 111
2013
Q2 		$26.4M Buy
+322,413
New +$24.1M 0.2% 119

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Commonwealth Bank of Australia's ELV Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 44,528 shares — an estimated $12.6M sold.

Commonwealth Bank of Australia first reported a position in ELV in Q2 2013 and held it in 25 quarters. The position peaked at $29M in Q3 2013. 1,015 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 44,528 Elevance Health shares in Q3 2019, an estimated $12.6M.
  • Commonwealth Bank of Australia first reported a position in Elevance Health in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Elevance Health position peaked at $29M in Q3 2013.
  • 1,015 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.